Leukocytoclastic vasculitis associated with Chlamydia pneumoniae respiratory infection: A case report Authors: Neera N Vora, Hannah Todorowski, Michelle Paulson, Nitin Bhanot Published: 2026 ABSTRACT AbstractLeukocytoclastic vasculitis (LCV) is an immune complex–mediated small-vessel vasculitis commonly associated with infections, medications, autoimmune diseases, and malignancy. Although atypical respiratory pathogens have been linked to several extrapulmonary dermatologic manifestations, reports of LCV occurring in association with Chlamydia pneumoniae infection remain rare. We describe a case of biopsy-proven LCV occurring in temporal association with C. pneumoniae respiratory infection in a 36-year-old woman who developed upper respiratory symptoms followed two weeks later by a rapidly progressive purpuric rash involving the lower extremities, abdomen, and upper extremities. Associated symptoms included arthralgias, bilateral foot edema, abdominal pain, nausea, and vomiting. Chest radiography demonstrated patchy left upper lobe airspace opacity, and respiratory pathogen testing was positive for Chlamydia pneumoniae. Extensive infectious and autoimmune evaluation was otherwise unrevealing. Skin punch biopsy confirmed leukocytoclastic vasculitis with negative direct immunofluorescence studies. The patient was treated with doxycycline and systemic corticosteroids, resulting in marked clinical improvement. This case highlights the diagnostic challenges of infection-associated vasculitis, which may mimic primary autoimmune disease because of systemic symptoms and transient autoantibody positivity. Although causality cannot be established, C. pneumoniae was considered a possible associated infectious trigger given the temporal association between respiratory illness and rash onset, compatible radiographic findings, positive respiratory pathogen testing, and exclusion of alternative etiologies. Clinicians should consider atypical respiratory pathogens in the differential diagnosis of small-vessel vasculitis following respiratory illness.Keywords: Leukocytoclastic vasculitis, Chlamydia pneumoniae, Atypical pneumonia, Cutaneous vasculitis, Small-vessel vasculitis Introduction Leukocytoclastic vasculitis (LCV) is an immune complex–mediated small-vessel vasculitis typically presenting with palpable purpura involving the lower extremities. It may be idiopathic or occur secondary to infections, medications, autoimmune diseases, or malignancy [1]. Atypical respiratory pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae have been associated with a variety of extrapulmonary cutaneous manifestations, although reports of LCV occurring in association with C. pneumoniae infection remain rare [2], [3]. Case presentation A 36-year-old woman with a past medical history of opioid use disorder on buprenorphine–naloxone, previously treated hepatitis C infection, and generalized anxiety disorder developed upper respiratory symptoms including cough, nasal congestion, anosmia, ageusia, and decreased appetite approximately two weeks prior to presentation. Her young child had recently experienced a self-limited upper respiratory illness. Two days prior to hospitalization, she developed a pruritic burning rash on the lower extremities that progressively enlarged and spread proximally, prompting evaluation at an urgent care center, where she tested negative for SARS-CoV-2. Later the same day, she presented to the emergency department, where she received an intramuscular corticosteroid injection for presumed contact dermatitis. Despite treatment, the rash progressed with development of violaceous non-blanching macules and papules involving the lower extremities, abdomen, mons pubis, and upper extremities (Fig. 1). She also developed erythematous mucosal changes of the tongue. Chest radiography demonstrated patchy left upper lobe airspace opacity concerning for pneumonia (Fig. 2). Laboratory evaluation revealed mild leukocytosis (WBC 12.4 ×10⁹/L) and trace proteinuria with preserved renal function. The following day, she developed abdominal pain, nausea, vomiting, bilateral foot edema, and arthralgias involving the knees and elbows. Computed tomography of the abdomen and pelvis demonstrated mild jejunal wall thickening suggestive of an infectious or inflammatory process.The patient was transferred to our institution for rheumatologic and dermatologic evaluation. Clinical presentation of leukocytoclastic vasculitis. (A) Numerous non-blanching erythematous-to-violaceous macules and papules involving the abdomen and trunk. (B) Purpuric papules and plaques involving the lower extremities, consistent with cutaneous small-vessel vasculitis. Chest radiograph demonstrating patchy left upper lobe airspace opacity concerning for pneumonia. Dermatology and rheumatology consultations were obtained on admission. She was started on topical triamcinolone cream twice daily. Based on dermatology recommendations, she received pulse-dose intravenous methylprednisolone 100 mg once, followed by weight-based intravenous methylprednisolone 1 mg/kg/day divided every 12 h for suspected cutaneous vasculitis. Empiric doxycycline 100 mg twice daily was initiated to cover possible tick-borne illness. Rheumatology assessed the presentation as most consistent with leukocytoclastic vasculitis, with differential considerations including post-viral vasculitis, autoimmune etiologies, and IgA vasculitis. A punch biopsy of a left lower leg lesion was performed, and an extensive autoimmune and infectious workup was pursued. Laboratory evaluation revealed an elevated antistreptolysin O titer without recent symptoms of streptococcal pharyngitis or clinical features of acute rheumatic fever. Hepatitis C antibody remained positive with an undetectable viral load. Initial Lyme serology was equivocal, but confirmatory Lyme IgM and IgG antibodies were negative. HIV and additional viral studies including CMV, EBV, parvovirus, and HSV were negative. ANCA testing revealed c-ANCA positivity with negative PR3 antibodies, which was felt to be consistent with infection-associated inflammation rather than primary systemic vasculitis. A respiratory pathogen panel returned positive for Chlamydia pneumoniae, consistent with atypical pneumonia and correlating with the patient’s respiratory symptoms and radiographic findings. Infectious disease consultants considered the cutaneous vasculitis to be possibly associated with C. pneumoniae infection. Final skin punch biopsy results confirmed leukocytoclastic vasculitis with negative direct immunofluorescence studies for IgG, IgM, IgA, fibrinogen, and C3 (Fig. 3) (Relevant diagnostic findings are summarized in Table 1). Histopathologic findings of leukocytoclastic vasculitis. (A) Low-power hematoxylin and eosin staining demonstrating superficial and deep perivascular inflammatory infiltrates. (B) High-power view demonstrating neutrophilic infiltration of small vessel walls with leukocytoclasia, fibrinoid change, and nuclear debris, consistent with leukocytoclastic vasculitis. Table 1Summary of relevant diagnostic findings.CategoryFindingsInterpretationRespiratory evaluationRespiratory pathogen panel positive for Chlamydia pneumoniae; chest radiograph demonstrated patchy left upper lobe opacityConsistent with atypical pneumoniaSkin biopsyPunch biopsy demonstrated leukocytoclastic vasculitis with fibrinoid necrosis, perivascular neutrophilic infiltrates, and karyorrhexis; direct immunofluorescence negative for IgG, IgM, IgA, fibrinogen, and C3Confirms LCVLyme disease evaluationInitial Lyme serology equivocal; confirmatory Lyme IgM and IgG antibodies negativeLyme disease unlikelyStreptococcal evaluationElevated antistreptolysin O and anti-DNase B titers; beta-hemolytic streptococcal throat culture negativeNo evidence of active streptococcal infectionAutoimmune evaluationc-ANCA positive (1:20); anti-proteinase 3 (PR3) antibodies negativeFavored infection-associated immune activation rather than primary ANCA-associated vasculitisInflammatory markerC-reactive protein: 7.6 mg/dLConsistent with systemic inflammationViral evaluationHIV, CMV, EBV, HSV-1/2, parvovirus IgM, and SARS-CoV-2 testing negativeNo alternative viral etiology identifiedHepatitis C evaluationHepatitis C antibody positive; HCV RNA quantitative PCR negativePrior treated infection; no active viremiaRenal evaluationUrinalysis: trace proteinuria; renal function preservedNo significant renal involvement Summary of relevant diagnostic findings. ANCA-anti-neutrophil cytoplasmic antibody, CMV-cytomegalovirus, EBV-Epstein–Barr virus, HSV-herpes simplex virus, HCV-hepatitis C virus, LCV-leukocytoclastic vasculitis. Due to prior intolerance to azithromycin, doxycycline was continued for a planned 10-day course. Following four days of treatment with doxycycline and intravenous methylprednisolone (32 mg twice daily), the patient demonstrated marked improvement in rash, arthralgias, edema, and systemic symptoms. She was transitioned to an oral prednisone taper and discharged in stable condition with doxycycline to complete a 10-day course, along with prednisone 50 mg daily for 7 days followed by weekly tapering by 10 mg to discontinuation. Outpatient dermatology follow-up was arranged, and her rash continued to improve with completion of antimicrobial therapy and corticosteroid taper. Discussion LCV is a small vessel vasculitis characterized histologically by neutrophilic inflammation of postcapillary venules with leukocytoclasia and fibrinoid vascular injury. Infectious triggers are well recognized and include bacterial infections such as streptococcal upper respiratory infections, viral infections including hepatitis B, hepatitis C, HIV, and upper respiratory viral illnesses, as well as atypical respiratory pathogens like Mycoplasma pneumoniae and Chlamydia pneumoniae [1], [2]. Reported dermatologic manifestations of Chlamydia pneumoniae infection include urticaria, erythema multiforme, erythema nodosum, and small vessel vasculitic eruptions [2], [3]. In this case, C. pneumoniae represented a biologically plausible but unproven trigger for LCV, supported by the temporal association between respiratory symptoms and rash onset, radiographic findings consistent with atypical pneumonia, positive respiratory pathogen testing, and exclusion of alternative infectious etiologies. Experimental studies have demonstrated that C. pneumoniae can infect endothelial cells and promote NF-κB–mediated endothelial activation with increased leukocyte adhesion and migration, mechanisms potentially contributing to vascular inflammation [4], [5]. Although immunologic complications related to C. pneumoniae are uncommon, prior reports have described leukocytoclastic vasculitis and other vasculitic syndromes occurring in association with chlamydial infections, including Chlamydia trachomatis seroconversion-associated cutaneous vasculitis and Chlamydia psittaci–associated temporal arteritis [6], [7], [8]. However, causality cannot be established from this case alone. This case highlights the diagnostic challenges of infection-associated vasculitis, which may mimic primary autoimmune disease because of systemic symptoms and transient autoantibody positivity. Systemic corticosteroids are a well-established treatment for symptomatic leukocytoclastic vasculitis, making interpretation of treatment response challenging in this case. Consequently, the concurrent initiation of doxycycline and corticosteroid therapy limits interpretation of the relative contribution of antimicrobial therapy and precludes causal inference regarding C. pneumoniae as the definitive etiologic trigger. Conclusion This case describes biopsy-proven leukocytoclastic vasculitis occurring in association with Chlamydia pneumoniae respiratory infection. Although causality cannot be established, atypical respiratory pathogens should be considered in the differential diagnosis of small-vessel vasculitis following respiratory illness. CRediT authorship contribution statement Hannah Todorowski: Supervision. Michelle Paulson: Writing – review & editing. Nitin Bhanot: Writing – review & editing, Supervision. Vora Neera: Writing – review & editing, Writing – original draft, Resources, Conceptualization. Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. References